Ambipar Emergency Response
AMBIQ
$0.51
$0.1128.30%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 139.81M | 182.44M | 142.09M | 137.17M | 149.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 139.81M | 182.44M | 142.09M | 137.17M | 149.62M |
| Cost of Revenue | 128.66M | 152.88M | 119.00M | 111.04M | 119.97M |
| Gross Profit | 11.15M | 29.56M | 23.09M | 26.13M | 29.65M |
| SG&A Expenses | 1.49M | 1.21M | 1.59M | 1.74M | 1.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -5.18M | -274.10K | -2.29M | 900.30K | 1.38M |
| Total Operating Expenses | 124.97M | 153.82M | 118.29M | 113.68M | 122.65M |
| Operating Income | 14.84M | 28.62M | 23.80M | 23.49M | 26.96M |
| Income Before Tax | -10.51M | 9.16M | 15.93M | 10.99M | 1.03M |
| Income Tax Expenses | 3.65M | 5.71M | -1.19M | 4.28M | 4.26M |
| Earnings from Continuing Operations | -14.16M | 3.45M | 17.11M | 6.71M | -3.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.88M | -2.13M | -4.67M | -5.32M | -2.92M |
| Net Income | -17.04M | 1.32M | 12.45M | 1.38M | -6.15M |
| EBIT | 14.84M | 28.62M | 23.80M | 23.49M | 26.96M |
| EBITDA | 23.64M | 36.07M | 31.06M | 30.47M | 33.94M |
| EPS Basic | -0.31 | 0.02 | 0.22 | 0.03 | -0.11 |
| Normalized Basic EPS | -0.17 | 0.06 | 0.10 | 0.03 | -0.04 |
| EPS Diluted | -0.31 | 0.02 | 0.17 | 0.02 | -0.11 |
| Normalized Diluted EPS | -0.17 | 0.06 | 0.07 | 0.02 | -0.04 |
| Average Basic Shares Outstanding | 55.43M | 55.43M | 55.43M | 55.43M | 55.43M |
| Average Diluted Shares Outstanding | 55.43M | 55.43M | 71.61M | 71.61M | 55.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -4.99% | 579.48% | 6.74% | -- | -- |